CEMIP and breast carcinoma: Taking expression analysis and correlation analysis into account, we speculated that EZH2, EGR1, and JUN might be the most potential upstream TFs of CEMIP. Thereby, expression and survival analyses were further carried out using the Breast Cancer Gene-Expression Miner.